Macrophage-Biomimetic Nanoparticles Ameliorate Ulcerative Colitis through Reducing Inflammatory Factors Expression

Macrophage-Biomimetic Nanoparticles Ameliorate Ulcerative Colitis through Reducing Inflammatory Factors Expression

Background and Aims: Inflammatory mediator S100A9 is dramatically elevated in ulcerative colitis and correlates with disease severity. S100A9 is a potential molecule to target for the treatment of colitis, but to date, there is no effective targeting method. The aim of this study was to develop a sa...

Full description

Bibliographic Details
Main Authors: Zhengshuo Li, Xiaoyue Zhang, Can Liu, Qiu Peng, Yangge Wu, Yuqing Wen, Run Zheng, Qun Yan, Jian Ma
Format: Article
Language:English
Published: Karger Publishers 2021-11-01
Series:Journal of Innate Immunity
Subjects:
ulcerative colitis
s100a9 inhibitor
biomimetic nanoparticles
drug delivery system
Online Access:https://www.karger.com/Article/FullText/519363

Internet

https://www.karger.com/Article/FullText/519363

Similar Items